A self-guided tinnitus app beat a sham control in a small double-blind trial

A smartphone app that delivers cognitive behavioural therapy and educational counselling for tinnitus reduced patients' distress substantially more than a sham app in a small, double-blind randomised trial [s1]. A digital therapeutic is exactly that — software prescribed as a treatment, here an app that walks a user through the same psychological techniques a therapist would, without a therapist in the room. The trial's result is genuinely positive, but the numbers that qualify it — 60 participants, a manufacturer's funding, and an underlying evidence base the authoritative review rates as low-certainty — are the ones that decide how much weight it can carry [s1][s2].

Why an app, and why for tinnitus

Tinnitus — the perception of sound with no external source — has no cure that reliably silences it. The interventions with the best evidence do not target the noise at all; they target the distress and functional impairment it causes, and cognitive behavioural therapy is the front-line psychological approach [s2]. The problem is access: trained CBT therapists are scarce and appointments are limited, so most people with distressing tinnitus never receive the one treatment shown to help. An app is an attempt to package that therapy into something scalable — the same logic behind digital therapeutics for insomnia, pain and depression.

What the trial did

The study, published in JAMA Otolaryngology–Head & Neck Surgery on 1 July 2026, was a double-blind, sham-controlled randomised trial run in Japan from September 2023 to February 2025 [s1]. Sixty adults with mild-to-severe chronic tinnitus were randomised evenly: 30 used the therapeutic app, and 30 used a sham control app that looked similar but lacked the therapeutic functions [s1]. The median age was 58.5 years (IQR, 52.0–64.0) and 33 participants (55%) were female [s1]. The treatment phase ran 16 weeks; during an 8-week follow-up the app's therapeutic functions were switched off, leaving only its recording feature, so the trial could see whether any benefit persisted once active treatment stopped [s1].

The primary outcome was the change from baseline to week 16 in the Tinnitus Handicap Inventory (THI), a standard questionnaire that scores tinnitus-related distress and functional impairment [s1]. The overall mean baseline THI was 41.3 (SD, 16.9) — moderate handicap [s1].

What it found

At 16 weeks, the therapeutic-app group improved substantially more than the sham group: the between-group difference in THI change was −20.4 points (95% CI, −28.2 to −12.6) [s1]. That effect largely held through the follow-up, with a mean between-group difference of −18.3 points (95% CI, −26.4 to −10.1) at week 24 — after the therapeutic functions had been turned off [s1]. Tinnitus worsened in one patient in the sham group, and no serious adverse events or hazardous device malfunctions were reported [s1].

The size of that difference is what makes the result interesting rather than trivial. For context, the Cochrane review of CBT for tinnitus estimates the minimal clinically important difference on the THI at about 7 points [s2]. A 20-point separation from sham is comfortably beyond that threshold, and the persistence at 24 weeks argues the app was teaching skills rather than merely distracting users while they engaged with it.

The reasons to hold the enthusiasm in check

Three caveats sit on top of the finding. The first is size: 60 participants, 30 per arm, is a prototype-scale trial, and the confidence intervals are correspondingly wide [s1]. The second is funding and authorship. The trial was supported by Kyorin Pharmaceutical, the company developing the app, and two of the authors are Kyorin employees, with the lead and other authors reporting grants or personal fees from the company [s1]. That does not void a randomised, sham-controlled, double-blind design — the strongest available for this question — but it is the provenance a reader should weigh, and it points to the need for independent replication.

The third is the foundation the app is built on. The Cochrane review that anchors CBT for tinnitus pooled 28 studies and 2,733 participants and concluded that CBT may reduce the impact of tinnitus on quality of life versus no treatment — a standardised mean difference of −0.56 (95% CI, −0.83 to −0.30) — but graded that evidence as low-certainty, meaning future studies could well shift the estimate [s2]. It found CBT probably makes little or no difference in serious adverse effects, and only a slight, low-certainty reduction in depression (SMD −0.34; 95% CI, −0.60 to −0.08) [s2]. A well-run app trial does not lift the certainty of the whole field; it adds one more data point to a body of evidence that is real but not yet firm.

What to watch

This is a promising, honestly reported trial of a scalable delivery method for a treatment that helps but is hard to obtain — not proof that a downloadable app should replace clinician-delivered care. The results a reader should wait for are the ordinary confirmatory ones: a larger trial, run by investigators without a commercial stake, in a different population, ideally comparing the app against real audiological or psychological care rather than a sham. For the broader picture, see our review of why no treatment reliably silences tinnitus, what a digital-therapeutic clearance actually means for effect sizes, and the evidence gaps NICE has flagged in digital mental-health tools.

Sources

• Mobile Application as a Digital Therapeutic for Chronic Tinnitus: A Randomized Clinical Trial — JAMA Otolaryngology–Head & Neck Surgery, 2026-07-01
• Cognitive behavioural therapy for tinnitus — Cochrane Database of Systematic Reviews, 2020-01-08